EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aerococcus viridans Phage Lysin AVPL Had Lytic Activity against Streptococcus suis in a Mouse Bacteremia Model

Hengyu Xi, Yao Fu, Chong Chen, Xin Feng iD, Wenyu Han, Jingmin Gu iD, Yalu Ji

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242316670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hengyu Xi und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Bacteriophages, Aerococcus, Streptococcus suis, Streptococcal Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus suis (S. suis) is a swine pathogen that can cause sepsis, meningitis, endocarditis, and other infectious diseases; it is also a zoonotic pathogen that has caused a global surge in fatal human infections. The widespread prevalence of multidrug-resistant S. suis strains and the decline in novel antibiotic candidates have necessitated the development of alternative antimicrobial agents. In this study, AVPL, the Aerococcus viridans (A. viridans) phage lysin, was found to exhibit efficient bactericidal activity and broad lytic activity against multiple serotypes of S. suis. A final concentration of 300 μg/mL AVPL reduced S. suis counts by 4–4.5 log10 within 1 h in vitro. Importantly, AVPL effectively inhibited 48 h S. suis biofilm formation and disrupted preformed biofilms. In a mouse model, 300 μg/mouse AVPL protected 100% of mice from infection following the administration of lethal doses of multidrug-resistant S. suis type 2 (SS2) strain SC19, reduced the bacterial load in different organs, and effectively alleviated inflammation and histopathological damage in infected mice. These data suggest that AVPL is a valuable candidate antimicrobial agent for treating S. suis infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriophagesAerococcusStreptococcus suisStreptococcal InfectionsBacteremiaAnimalsSwineHumansMiceDisease Models, Animal

Stichwörter der Autor:innen

Aerococcus viridansStreptococcus suisbacteremiabiofilmphage lysin

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin Un…
  • Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.

ORCID-Profile: Xin Feng, Jingmin Gu

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Xi, H., Fu, Y., Chen, C., Feng, X., Han, W., Gu, J., & Ji, Y. (2023). Aerococcus viridans Phage Lysin AVPL Had Lytic Activity against Streptococcus suis in a Mouse Bacteremia Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316670

Vancouver

Xi H, Fu Y, Chen C, Feng X, Han W, Gu J, et al. Aerococcus viridans Phage Lysin AVPL Had Lytic Activity against Streptococcus suis in a Mouse Bacteremia Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316670

BibTeX
@article{Xi2023,
  author = {Xi, Hengyu and Fu, Yao and Chen, Chong and Feng, Xin and Han, Wenyu and Gu, Jingmin and Ji, Yalu},
  title = {Aerococcus viridans Phage Lysin AVPL Had Lytic Activity against Streptococcus suis in a Mouse Bacteremia Model},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242316670}
}
Kostenlos starten →